News

Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine. The vaccine candidate developed by Sanofi…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib) for the treatment of BRAF V600…
Read More...

SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce fully human polyclonal antibodies without the need for human…
Read More...

Teva Pharmaceutical Industries Ltd. who holds (through its Japanese affiliates) with Takeda a joint business venture in the Japanese market, announced a new strategy for its local…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational drug pevonedistat for…
Read More...

Sangamo Therapeutics, Inc. announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene regulation therapies to address…
Read More...

Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The vaccine candidate,…
Read More...

Johnson & Johnson announced that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies. The data, published…
Read More...

Harbour BioMed (HBM) and Viva Biotech (Shanghai) Ltd. announced a strategic partnership under which both parties will collate their respective expertise in drug discovery and…
Read More...

UCB announced an agreement to enter into a world-wide, exclusive license agreement with Roche and Genentech, a member of the Roche Group, for the global development and…
Read More...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical contract development and…
Read More...

Piramal Pharma Solutions announced that it is providing Bolt Biotherapeutics (Bolt) with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing…
Read More...

At the direction of President Donald J. Trump, U.S. International Development Finance Corporation (DFC) Chief Executive Officer Adam Boehler will today sign a letter of interest (LOI)…
Read More...

Karuna Therapeutics, Inc. an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with…
Read More...

Viva Biotech Holdings and Schrödinger, Inc. announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of…
Read More...

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced receipt of IND clearance from the US Federal Drug Administration (FDA) to evaluate NT-I7…
Read More...

Zentalis Pharmaceuticals, Inc. announced a clinical collaboration agreement with Eli Lilly and Company in which Zentalis will evaluate the combination of ZN-c5, the Company’s oral…
Read More...

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables…
Read More...

AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for DS-1062, Daiichi Sankyo’s proprietary…
Read More...

Emergent BioSolutions Inc. announced that it has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance…
Read More...